News

Morphogen-IX has attracted seed funding to develop a new treatment for pulmonary arterial hypertension (PAH). This potential treatment based on 15 years of research by Prof Nick Morrell and others will target the major pathway implicated in genetic studies of patients and, if successful, will provide the first disease-...

In a research project funded by the British Heart Foundation, Ms Victoria Mascetti and Professor Roger Pedersen have shown that it is possible to successfully transplant human pluripotent stem cells (hPSC) into the mouse embryo and that they then develop and grow normally. hPSCs come from two sources for use in...

New research led by Dr Anthony Davenport and Dr James Rudd shows that unstable plaques in arteries can be reliably identified using sodium fluoride and PET/CT scanning. The technique could help in the early diagnosis of high-risk patients and in the development of new therapeutics. Atherosclerosis – hardening of the...

A study led by Professor Nick Morrell has used a recombinant protein to successfully treat pulmonary arterial hypertension (PAH) in three animal models and in human endothelial cell cultures. PAH is a debilitating disease that affects the blood vessels in the lungs and leads to heart failure. Currently the only available...